CYTKCytokinetics, Incorporated

$75.36

What is the market doing?

What the tape says about CYTK

Cytokinetics, Incorporated is +93% over the past year while the S&P 500 is +20%: 73 points ahead of the market.

+93%

1-year return · S&P 500 +20%

vs 200-day average
+10%

vs 200-day average · a clear uptrend

RSI (14)
49

RSI (14) · neutral

Below its 52-week high
11%

Below its 52-week high

2024-08-15$29.84 – $84.88 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$75.36
1 monthS&P 500 −0.30%
−0.79%
1 yearS&P 500 +20%
+93%
5 yearsS&P 500 +85%
+132%
vs 50-day average$76.93
−2.1%
52-week high
$84.88
52-week low
$35.33
Annualised volatility
55%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$4.7M
Calendar-year price return
YearReturn
2026 (year to date)+19%
2025+35%
2024−44%
2023+82%
2022+0.53%
2021+119%
2020+96%
2019+68%
2018−22%
2017−33%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10−1.6%
Feb105 of 10−1.1%
Mar105 of 10+1.1%
Apr108 of 10+9.5%
May106 of 10+0.39%
Jun105 of 10+0.30%
Jul118 of 11+9.4%
Aug118 of 11+6.2%
Sep114 of 11+0.76%
Oct104 of 10−4.0%
Nov106 of 10+1.1%
Dec106 of 10+17%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.